
The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc's experimental cannabis-derived epilepsy drug "orphan" status for a third group of patients affected by a rare form of the disease.
The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc's experimental cannabis-derived epilepsy drug "orphan" status for a third group of patients affected by a rare form of the disease.
In states where it is legal to use medical marijuana to manage chronic pain and other conditions, the annual number of deaths from prescription drug overdose is 25 percent lower than in states where medical marijuana remains illegal, new research suggests.
PHOENIX (KPHO/KTVK) - The Drug Enforcement Administration has approved a first-of-its-kind trial to study the effects of medical marijuana as a treatment for post-traumatic stress disorder in veterans.
A group of more than 50 physicians, including a former surgeon general and faculty members at some of the nation's leading medical schools, has formed the first national organization of doctors to call on states and the federal government to legalize and regulate the use of marijuana in the interest of public health.
The medical cannabis market , despite an ongoing battle for its legalization in other states, is poised to exceed $40 billion worth of revenues over the next 10 years.
As is the case with humans, pets suffer side effects — including liver and kidney damage — from the medication they’re prescribed. But L.A. veterinarian Dr. Tim Shu says there’s a safe alternative for some of these prescriptions: medical marijuana.
Supporters of the new push to legalize medical marijuana in Ohio have added several new medical conditions to a proposed constitutional amendment, including chronic traumatic encephalopathy, or CTE.
An experimental drug derived from marijuana has succeeded in reducing epileptic seizures in its first major clinical trial, the product’s developer announced Monday, a finding that could lend credence to the medical marijuana movement.
Dozens of Iowans have decided not to wait for legislators to make the sale of medical marijuana legal in the state.
A proposal to allow minors with certain medical conditions to use marijuana for palliative purposes is back before legislators this year, this time with the backing of onetime opponents: pediatricians.
AURORA, Colo. - A baby girl who began having life-threatening seizures within days of her birth is receiving hemp oil while in the neonatal intensive-care unit at Children's Hospital Colorado, her mother says.
Medical marijuana industry advocates and observers say a dearth of doctors willing to recommend patients is among the hurdles Illinois’ fledgling industry needs to overcome.
Massachusetts Sen. Elizabeth Warren is urging the CDC to look into marijuana as a possible antidote to painkiller deaths.
Oregon should fund an independent marijuana institute to support and conduct world-class research into the drug's medical and public health benefits, says a task force that includes state officials, scientists and leading physicians.
The race is on for Hawaii medical marijuana dispensary licenses. The 50th state has had a medical marijuana program for 15 years and was the first state to legalize it through the legislative process back in 2000.
Ten years ago this month, Rhode Island legalized medical marijuana. Today, nearly 13,000 patients are enrolled, not to mention more than 2000 caregivers. And a hundred new applications arrive every week. Is it sustainable?
Marijuana can be used to effectively treat people suffering from migraine headaches, new research has found.
A new study involving 11 epilepsy centers across the United States shows that a drug made from a medical marijuana derivative can reduce seizures in children and young adults with epilepsy who don't find relief from other treatments.
Copyright 2019 - 2024. WeedWorthy.com is a news division of MjLink.com, Inc.. All rights reserved. WeedWorthy
To contact the following departments, dial 1-844-420-4208 - Sales: Ext. #2 - Support: Ext. #3 - Investor Relations: Ext. #6
By using this website, you agree and understand that, by law: You MUST be at least 21 years of age to view any content on this website. To view the complete Terms of Use and Privacy Policy for this website, Click Here!